Search research articles
Contact Us
Filters
Showing results (131-140 of 148) with videos related to
Page
of 15
Sort By:
Scientific Reports
|
November 25, 2016
Systemic and mucosal immune responses following oral adenoviral delivery of influenza vaccine to the human intestine by radio controlled capsule
Leesun Kim, C Josefina Martinez, Katie A Hodgson, et al.
Experimental Neurology
|
December 3, 2015
Low-dose, continual enzyme delivery ameliorates some aspects of established brain disease in a mouse model of a childhood-onset neurodegenerative disorder
Barbara King, Meghan L Setford, Sofia Hassiotis, et al.
Vaccine
|
January 30, 2013
Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-γ T cell responses in humans
Wendy Peters, Jennifer R Brandl, Jonathan D Lindbloom, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 30, 2016
Validating a Local Failure Risk Stratification for Use in Prospective Studies of Adjuvant Radiation Therapy for Bladder Cancer
Brian C Baumann, Jiwei He, Wei-Ting Hwang, et al.
Science Translational Medicine
|
May 5, 2022
Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model
Stephanie N Langel, Susan Johnson, Clarissa I Martinez, et al.
Cancer Research
|
March 10, 1999
Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer
O N Tucker, A J Dannenberg, E K Yang, et al.
Cancer
|
January 7, 2014
Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710
John P Christodouleas, Brian C Baumann, Jiwei He, et al.
The Journal of Infectious Diseases
|
October 20, 2019
Production and Clinical Evaluation of Norwalk GI.1 Virus Lot 001-09NV in Norovirus Vaccine Development
Roberto Mateo, Lisa C Lindesmith, Shaily J Garg, et al.
Science Translational Medicine
|
March 5, 2025
An oral norovirus vaccine tablet was safe and elicited mucosal immunity in older adults in a phase 1b clinical trial
Becca A Flitter, Susan N Greco, Colin A Lester, et al.
Studies in Health Technology and Informatics
|
August 24, 2019
A Tale of Two Databases: The DoD and VA Infrastructure for Clinical Intelligence (DaVINCI)
Scott L DuVall, Michael E Matheny, Ildar R Ibragimov, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 148) with videos related to
Sort By:
Page
of 15
Scientific Reports
|
November 25, 2016
Systemic and mucosal immune responses following oral adenoviral delivery of influenza vaccine to the human intestine by radio controlled capsule
Leesun Kim, C Josefina Martinez, Katie A Hodgson, et al.
Experimental Neurology
|
December 3, 2015
Low-dose, continual enzyme delivery ameliorates some aspects of established brain disease in a mouse model of a childhood-onset neurodegenerative disorder
Barbara King, Meghan L Setford, Sofia Hassiotis, et al.
Vaccine
|
January 30, 2013
Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-γ T cell responses in humans
Wendy Peters, Jennifer R Brandl, Jonathan D Lindbloom, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 30, 2016
Validating a Local Failure Risk Stratification for Use in Prospective Studies of Adjuvant Radiation Therapy for Bladder Cancer
Brian C Baumann, Jiwei He, Wei-Ting Hwang, et al.
Science Translational Medicine
|
May 5, 2022
Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model
Stephanie N Langel, Susan Johnson, Clarissa I Martinez, et al.
Cancer Research
|
March 10, 1999
Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer
O N Tucker, A J Dannenberg, E K Yang, et al.
Cancer
|
January 7, 2014
Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710
John P Christodouleas, Brian C Baumann, Jiwei He, et al.
The Journal of Infectious Diseases
|
October 20, 2019
Production and Clinical Evaluation of Norwalk GI.1 Virus Lot 001-09NV in Norovirus Vaccine Development
Roberto Mateo, Lisa C Lindesmith, Shaily J Garg, et al.
Science Translational Medicine
|
March 5, 2025
An oral norovirus vaccine tablet was safe and elicited mucosal immunity in older adults in a phase 1b clinical trial
Becca A Flitter, Susan N Greco, Colin A Lester, et al.
Studies in Health Technology and Informatics
|
August 24, 2019
A Tale of Two Databases: The DoD and VA Infrastructure for Clinical Intelligence (DaVINCI)
Scott L DuVall, Michael E Matheny, Ildar R Ibragimov, et al.
Page
of 15